Exploring how LGBTQ+ microaggressions affect cancer genetic counseling for Black patients
Understanding the Nature and Impact of LGBTQ+ Microaggressions in Cancer Genetic Counseling Encounters
This study is looking at how Black patients feel during cancer genetic counseling, especially when they face subtle discrimination related to being LGBTQ+, to see how it affects their communication and care compared to White patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-11015248 on NIH RePORTER |
What this research studies
This research investigates the experiences of Black patients during cancer genetic counseling, particularly focusing on the impact of LGBTQ+ microaggressions. It aims to understand how these subtle forms of discrimination affect communication and the quality of care received. By comparing encounters between Black and White patients, the study seeks to identify disparities in patient-provider interactions and clinical recommendations. The research will utilize surveys and interviews to gather data on patient experiences and outcomes in a clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black individuals seeking cancer genetic counseling, particularly those who identify as LGBTQ+.
Not a fit: Patients who do not identify as Black or do not seek cancer genetic counseling may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved communication and care for Black patients in cancer genetic counseling, ultimately reducing health disparities.
How similar studies have performed: Previous research has shown that addressing implicit biases in healthcare can improve patient outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Quillin, John M. — Virginia Commonwealth University
- Study coordinator: Quillin, John M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.